← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 4, 2017Last known activity
Apr 14, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (11 distinct, 7 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (5 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (12)
- NCT06845345Lead sponsorPhase 4Apr 14, 2025
- NCT06845345Sponsor investigatorPhase 4Apr 14, 2025
- NCT05831566Sponsor investigatorPhase 3Jan 31, 2023
- NCT05831566Lead sponsorPhase 3Jan 31, 2023
- NCT05831566Reponsible party - principal investigatorPhase 3Jan 31, 2023
- NCT05652699CollaboratorN/AOct 1, 2022
- NCT05464394Lead sponsorPhase 3Sep 1, 2022
- NCT05063149Reponsible party - principal investigatorPhase 3Oct 31, 2021
- NCT05063149Lead sponsorPhase 3Oct 31, 2021
- NCT05693688CollaboratorPhase 4Dec 1, 2017
- NCT03247920Reponsible party - principal investigatorPhase 4Nov 4, 2017
- NCT03247920Lead sponsorPhase 4Nov 4, 2017
Details
- Last known activity
- Apr 14, 2025